Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5048)
All Articles published online
|
Publishing Process of This Article
|
Jan 26, 2022 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vicinanza C, Lombardi E, Da Ros F, Marangon M, Durante C, Mazzucato M, Agostini F. Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications. World J Stem Cells 2022; 14(1): 54-75 [PMID: 35126828 DOI: 10.4252/wjsc.v14.i1.54] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v14/i1/54.htm |
| Number | Citing Articles |
| 1 |
Cosette M. Rivera-Cruz, Shreya Kumar, Marxa L. Figueiredo. Poly I:C-priming of adipose-derived mesenchymal stromal cells promotes a pro-tumorigenic phenotype in an immunocompetent mouse model of prostate cancer. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1145421
|
| 2 |
Francesco Da Ros, Kinga Kowal, Carla Vicinanza, Elisabetta Lombardi, Francesco Agostini, Rosanna Ciancia, Maurizio Rupolo, Cristina Durante, Mariagrazia Michieli, Mario Mazzucato. IRE1a-Induced FilaminA Phosphorylation Enhances Migration of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients. Cells 2023; 12(15): 1935 doi: 10.3390/cells12151935
|
| 3 |
Ahmed Faris Aldoghachi, Zhi Xiong Chong, Swee Keong Yeap, Soon Keng Cheong, Wan Yong Ho, Alan Han Kiat Ong. Stem Cells for Cancer Therapy: Translating the Uncertainties and Possibilities of Stem Cell Properties into Opportunities for Effective Cancer Therapy. International Journal of Molecular Sciences 2023; 24(2): 1012 doi: 10.3390/ijms24021012
|
| 4 |
Xinrun Zhou, Wen Zhang, Yue Liu, Leisheng Zhang, Zongjin Li. Mesenchymal Stem Cells. 2023; : 119 doi: 10.1016/B978-0-323-95346-7.00001-4
|
| 5 |
Maryam Dolatshahi, Ahmad Reza Bahrami, Qaiser Iftikhar Sheikh, Mohsen Ghanbari, Maryam M. Matin. Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles. Archives of Pharmacal Research 2024; 47(1): 1 doi: 10.1007/s12272-023-01477-8
|
| 6 |
Zhilong Ma, Jie Hua, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, Jin Xu. Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges. International Journal of Molecular Sciences 2023; 24(4): 3559 doi: 10.3390/ijms24043559
|
| 7 |
Mohsen Karami Fath, Zahra Moayedi Banan, Reza Barati, Omid Mohammadrezakhani, Aliasghar Ghaderi, Ali Hatami, Shamim Ghiabi, Nazanin Zeidi, Katayoon Asgari, Zahra Payandeh, Ghasem Barati. Recent advancements to engineer mesenchymal stem cells and their extracellular vesicles for targeting and destroying tumors. Progress in Biophysics and Molecular Biology 2023; 178: 1 doi: 10.1016/j.pbiomolbio.2023.02.001
|
| 8 |
Munire Abudurexiti, Yue Zhao, Xiaoling Wang, Lu Han, Tianqing Liu, Chengwei Wang, Zhixiang Yuan. Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery. Pharmaceutics 2023; 15(7): 2011 doi: 10.3390/pharmaceutics15072011
|
| 9 |
Forough Shams, Bahareh Pourjabbar, Nader Hashemi, Navid Farahmandian, Ali Golchin, Ghader Nuoroozi, Azam Rahimpour. Current progress in engineered and nano-engineered mesenchymal stem cells for cancer: From mechanisms to therapy. Biomedicine & Pharmacotherapy 2023; 167: 115505 doi: 10.1016/j.biopha.2023.115505
|
| 10 |
Carsten W. Lederer, Lola Koniali, Tina Buerki-Thurnherr, Panayiota L. Papasavva, Stefania La Grutta, Amelia Licari, Frantisek Staud, Donato Bonifazi, Marina Kleanthous. Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies. Pharmaceutics 2022; 14(4): 793 doi: 10.3390/pharmaceutics14040793
|
| 11 |
Kai-Hung Wang, Dah-Ching Ding. Role of cancer-associated mesenchymal stem cells in the tumor microenvironment: A review. Tzu Chi Medical Journal 2023; 35(1): 24 doi: 10.4103/tcmj.tcmj_138_22
|
| 12 |
Abdullah Al Subayyil, Yasser S. Basmaeil, Hayaa Bin Kulayb, Maha Alrodayyan, Lama Abdulaziz A. Alhaber, Taghreed N. Almanaa, Tanvir Khatlani. Preconditioned Chorionic Villus Mesenchymal Stem/Stromal Cells (CVMSCs) Minimize the Invasive Phenotypes of Breast Cancer Cell Line MDA231 In Vitro. International Journal of Molecular Sciences 2023; 24(11): 9569 doi: 10.3390/ijms24119569
|
| 13 |
Mohsen Karami Fath, Samaneh Mohammad Bagherzadeh Torbati, Vahid Saqagandomabadi, Omid Yousefi Afshar, Mohammad Khalilzad, Sara Abedi, Afshin Moliani, Danyal Daneshdoust, Ghasem Barati. The therapeutic effect of MSCs and their extracellular vesicles on neuroblastoma. Progress in Biophysics and Molecular Biology 2024; 187: 51 doi: 10.1016/j.pbiomolbio.2024.02.004
|
| 14 |
Jonas Steenbrugge, Glenn Pauwelyn, Kristel Demeyere, Nausikaa Devriendt, Hilde de Rooster, Niek N. Sanders, Jan H. Spaas, Evelyne Meyer. Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1252374
|